Targeted pharmacological reversal of electrical remodeling after cardioversion
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Flecainide (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms Flec-SL
- 02 Jul 2012 Additional lead trial centres and investigator, actual patient number 760 added as reported by ClinicalTrials.gov.
- 22 Jun 2012 Results published in the Lancet.
- 02 May 2011 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History